OBJECTIVE: Decreased fetal heart rate variability is associated with higher perinatal morbidity and mortality in intrauterine growth restriction (IUGR). This study used a new method [phase-rectified signal averaging (PRSA)] to calculate acceleration- and deceleration-related fluctuations of the fetal heart rate. METHOD: Cardiotocograms from 74 growth-restricted and 161 normal fetuses were included. Both groups were matched for gestational age. The transformed PRSA signal was quantified by the acceleration-related parameter-averaged acceleration capacity (AAC) and compared to the standard short-term variation (STV). Mann-Whitney test and receiver operator characteristic (ROC) curves were used for statistical analysis. RESULTS: For AAC, the median values of the IUGR group and control group were 1.97 bpm [interquartile range (IQR): 1.66-2.23] and 2.49 bpm (IQR: 2.24-2.72), respectively. For STV, these values were 5.44 ms (IQR: 4.49-7.38) and 7.79 ms (IQR: 6.35-9.66), respectively. The area under the ROC curve was 81.4% for AAC and 70.5% for STV. CONCLUSION: The results of AAC are in both groups comparable to STV. Longitudinal studies are needed to investigate the association of AAC with the clinical outcome of the newborn.
OBJECTIVE: Decreased fetal heart rate variability is associated with higher perinatal morbidity and mortality in intrauterine growth restriction (IUGR). This study used a new method [phase-rectified signal averaging (PRSA)] to calculate acceleration- and deceleration-related fluctuations of the fetal heart rate. METHOD: Cardiotocograms from 74 growth-restricted and 161 normal fetuses were included. Both groups were matched for gestational age. The transformed PRSA signal was quantified by the acceleration-related parameter-averaged acceleration capacity (AAC) and compared to the standard short-term variation (STV). Mann-Whitney test and receiver operator characteristic (ROC) curves were used for statistical analysis. RESULTS: For AAC, the median values of the IUGR group and control group were 1.97 bpm [interquartile range (IQR): 1.66-2.23] and 2.49 bpm (IQR: 2.24-2.72), respectively. For STV, these values were 5.44 ms (IQR: 4.49-7.38) and 7.79 ms (IQR: 6.35-9.66), respectively. The area under the ROC curve was 81.4% for AAC and 70.5% for STV. CONCLUSION: The results of AAC are in both groups comparable to STV. Longitudinal studies are needed to investigate the association of AAC with the clinical outcome of the newborn.
Authors: Dirk Hoyer; Jan Żebrowski; Dirk Cysarz; Hernâni Gonçalves; Adelina Pytlik; Célia Amorim-Costa; João Bernardes; Diogo Ayres-de-Campos; Otto W Witte; Ekkehard Schleußner; Lisa Stroux; Christopher Redman; Antoniya Georgieva; Stephen Payne; Gari Clifford; Maria G Signorini; Giovanni Magenes; Fernando Andreotti; Hagen Malberg; Sebastian Zaunseder; Igor Lakhno; Uwe Schneider Journal: Physiol Meas Date: 2017-02-10 Impact factor: 2.833
Authors: Bhargavi Sriram; Margret A Mencer; Samantha McKelvey; Eric R Siegel; Srinivasan Vairavan; James D Wilson; Hubert Preissl; Hari Eswaran; Rathinaswamy B Govindan Journal: Early Hum Dev Date: 2013-07-29 Impact factor: 2.079
Authors: Tong Chen; Guanchao Feng; Cassandra Heiselman; J Gerald Quirk; Petar M Djurić Journal: Proc IEEE Int Conf Acoust Speech Signal Process Date: 2022-04-27
Authors: Lisa Stroux; Christopher W Redman; Antoniya Georgieva; Stephen J Payne; Gari D Clifford Journal: Acta Obstet Gynecol Scand Date: 2017-09-27 Impact factor: 3.636
Authors: Marta C Antonelli; Martin G Frasch; Mercedes Rumi; Ritika Sharma; Peter Zimmermann; Maria S Molinet; Silvia M Lobmaier Journal: Curr Neuropharmacol Date: 2022 Impact factor: 7.708
Authors: Massimo W Rivolta; Tamara Stampalija; Daniela Casati; Bryan S Richardson; Michael G Ross; Martin G Frasch; Axel Bauer; Enrico Ferrazzi; Roberto Sassi Journal: PLoS One Date: 2014-08-20 Impact factor: 3.240
Authors: N Giuliano; M L Annunziata; S Tagliaferri; F G Esposito; O C M Imperato; M Campanile; M G Signorini; A Di Lieto Journal: J Pregnancy Date: 2014-12-09